Breast Imaging Market worth $4.6 billion by 2023

1. MarketsandMarkets Presents Breast Imaging Market Insights on Scope and Growing Demands 2023 https://www.marketsandmarkets.com/Market-Reports/breast-imaging-technologies- market-897.html

2. ➢ [198 Pages Report] The breast imaging market is projected to grow from an estimated USD 3.1 billion in 2018 to USD 4.6 billion by 2023, at a CAGR of 8.0% during the forecast period. Market growth is largely driven by factors such as technological advancements, the rising prevalence of breast cancer, the increasing number of screening programs as well as rising number of conferences and symposiums focusing on spreading awareness about the benefits of early screening and diagnosis. The emerging markets, growing government and private investments to meet the increasing demand for breast cancer screening, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players. ➢ Based on technology, the breast imaging market is segmented into ionizing breast imaging, non-ionizing breast imaging, and other breast imaging technologies. The non-ionizing breast imaging segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the advantages offered by non-ionizing breast imaging technologies over ionizing breast imaging technologies, such as greater generation of anatomical details for diagnosis, high sensitivity to small breast lesions in women with dense breast tissues, and fewer false positives. https://www.marketsandmarkets.com/Market-Reports/breast-imaging-technologies- market-897.html

3. Early buyers will receive 10% customization on Reports. https://www.marketsandmarkets.com/Market-Reports/breast-imaging-technologies- market-897.html

4. ➢ The market for ionizing breast imaging technologies, by type, comprises mammography (analog mammography, full-field digital mammography, and 3D breast tomosynthesis), positron emission tomography-computed tomography (PET-CT), molecular breast imaging (MBI), and positron emission mammography (PEM). Mammography accounted for the largest share of the ionizing breast imaging technologies market in 2018. Its large share can be attributed to technological advancements in this segment and increasing awareness. ➢ Non-ionizing breast imaging technologies comprise breast ultrasound, breast MRI, automated whole-breast ultrasound (AWBU), and breast thermography. The breast ultrasound segment accounted for the largest share of the non- ionizing breast imaging technologies market in 2018 whereas the AWBU segment is estimated to witness the second-highest growth rate during the forecast period. The large share of the breast ultrasound segment can be attributed to the lower risk of exposure to radiation and the benefits offered by breast ultrasound such as the ability to detect lesions and the nature of lesions in women with dense breast tissues, the ability to differentiate between a cyst and a solid mass, and the detection of blood flow through vessels. https://www.marketsandmarkets.com/Market-Reports/breast-imaging-technologies- market-897.html

5. ➢ The Asia Pacific is one of the major revenue-generating regions in the breast imaging market. China, India, and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries focusing on the improvement of breast health. Furthermore, the increasing geriatric population and the growing incidence of breast cancer are also driving the growth of this regional market. ➢ Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), and Philips Healthcare (Netherlands) dominated the breast imaging market. Other players in this market include Fujifilm Holdings Corporation (Japan), Aurora Imaging Technology, Inc. (US), Canon Inc. (Japan), CMR Naviscan Corporation (US), Delphinus Medical Technologies, Inc. (US), Dilon Technologies, Inc. (US), KUB Technologies Inc. (Kubtec) (US), Micrima Limited (UK), Planmed Oy (Finland), SonoCiné, Inc. (US), and SuperSonic Imagine (France), among others. ➢ To speak to our analyst for a discussion on the above findings, click Speak to Analyst https://www.marketsandmarkets.com/Market-Reports/breast-imaging-technologies- market-897.html

6. About MarketsandMarkets MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. https://www.marketsandmarkets.com/Market-Reports/breast-imaging-technologies- market-897.html

7. Contact Us Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 Email: sales@marketsandmarkets.com Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market- reports/healthcare Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets https://www.marketsandmarkets.com/Market-Reports/breast-imaging-technologies- market-897.html